A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain

Withdrawn before enrolling · Not applicable

Conditions studied: Pain Management, Cancer Pain

In brief

The purpose of this study is to compare efficacy of pain treatment with ITDD to efficacy of pain treatment with CMM in patients with pancreatic cancer pain.

Key facts

Study ID

NCT02578459

Run by

Flowonix Medical

People needed

0

Starts

2016-04-01

Expected to finish

2018-09-01

Last updated by the study team

2019-02-15

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has Stage IV pancreatic cancer.
• Patient agrees not to be treated by other oncologists or anesthesiologists during the study.
• Patient agrees not to obtain pain medications from other physicians during the study.
• Patient is at least 22 years of age.
• Investigator considers the patient to be able and willing to fulfill all study requirements.
• Patient is able to understand the study and provide written informed consent to participate in the study.

You may not qualify if…

• Patient meets any of the contraindications for use of the Prometra Programmable Infusion System (for patients in the ITDD group).
• Patient is enrolled in another clinical study.

Where it is running

• Menorah Medical Center — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.